Age-related patterns of care: Evidence against ageism in the treatment of early-stage breast cancer

Journal of Clinical Oncology

Volumn 15, Issue 6, 1997, Pages 2338-2344

  Guadagnoli, Edward ^a   Shapiro, Charles ^a   Gurwitz, Jerry H ^a   Silliman, Rebecca A ^a   Weeks, Jane C ^a   Borbas, Catherine ^a   Soumerai, Stephen B ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0030947137     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.6.2338     Document Type: Article

References (27)

1. Castiglione M, Gelber RD, Goldhirsch A: Adjuvant systemic therapy for breast cancer in the elderly: Competing causes of mortality. J Clin Oncol 8:519-526, 1990
2. Cummings FJ, Gray R, Tormey DC, et al: Adjuvant tamoxifen versus placebo in elderly women with node positive breast cancer: Long-term follow-up and causes of death. J Clin Oncol 11:29-35, 1993
3. Goldhirsh A, Gelber RD, Castiglione M, et al: Present and future projects of the International Breast Cancer Study Group. Cancer 74:1139-1149, 1994
4. Early Breast Cancer Trialists' Collaborative Group: Systematic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Part 2. Lancet 339:71-85, 1992
5. Glick JH, Gelber RD, Goldhirsch A, et al: Meeting highlights: Adjuvant therapy for primary breast cancer. J Natl Cancer Inst 84:1479-1485, 1992
6. Goldhirsch A, Wood WC, Senn H-J, et al: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 87:1441-1445, 1995
7. Allen C, Cox EB, Manton KG, et al: Breast cancer in the elderly: Current patterns of care. J Am Geriatr Soc 34:637-642, 1986
8. Chu J, Diehr P, Feigl P, et al: The effect of age on the care of women with breast cancer in community hospitals. J Gerontol 42:185-190, 1987
9. Silliman RA, Guadagnoli E, Weitberg AB, et al: Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 44:M46-M50, 1989
10. Bergman L, Dekker G, van Leeuwen FE, et al: The effect of age on treatment choice and survival in elderly breast cancer patients. Cancer 67:2227-2234, 1991
11. Newcomb PA, Carbone PP: Cancer treatment and age: Patient perspectives. J Natl Cancer Inst 85:1580-1584, 1993
12. Greenfield S, Blanco DM, Elashoff RM, et al: Patterns of care related to age of breast cancer patients. JAMA 257:2766-2770, 1987
13. Marascuilo LA, McSweeney M: Nonparametric and Distribution-Free Methods for the Social Sciences. Monterey, CA, Brooks/Cole, 1977
14. Hosmer DW, Lemeshow S: Applied Regression Analysis. Toronto, Canada, Wiley, 1989
15. Christmas K, Muss HB, Case LD, et al: Chemotherapy of metastatic breast cancer in the elderly: The Piedmont Oncology Association experience. JAMA 268:57-62, 1992
16. Wood W, Budman DR, Korzun AH, et al: Dose and dose intensity of adjuvant chemotherapy for stage II, node positive breast carcinoma. N Engl J Med 330:1253-1259, 1994
17. Begg CB, Cohen JL, Ellerton J: Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group. Cancer Clin Trials 3:369-374, 1980
18. Bonadonna G, Valagussa P: Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304:10-15, 1981
19. Fentiman IS, Tirelli U, Monfardini S, et al: Cancer in the elderly: Why so badly treated? Lancet 335:1020-1022, 1990
20. Muss HB: The role of chemotherapy and adjuvant therapy in the management of breast cancer in older women. Cancer 74:2165-2171, 1994
21. NIH Consensus Conference: Treatment of early-stage breast cancer. JAMA 265:391-395, 1991
22. Love RR, Mazess RB, Barden HS, et al: Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852-856, 1992
23. Love RR, Wiebe DA, Newcomb PA, et al: Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med 115:860-864, 1991
24. McDonald CC, Stewart HJ: Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. BMJ 303:435-437, 1991
25. Rutqvist LE, Mattsson A: Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. J Natl Cancer Inst 85:1398-1406, 1993
26. Silliman RA, Balducci L, Goodwin JS, et al: Breast cancer in old age: What we know, don't know, and do. J Natl Cancer Inst 85:190-199, 1993
27. Samet J, Hunt WC, Key C, et al: Choice of cancer therapy varies with age of patient. JAMA 255:3385-3390, 1986